Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360442 (US9828369, Example 14 | ethyl 3-(8-((2- phenylcycl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360342 (US9828369, Example 3 | methyl 3-(8-(((1R,2R)-2- ph...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 82.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360337 (US9828369, Example 2 | methyl 3-(8-((2-(4-(trifluo...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 85.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360343 (US9828369, Example 4 | methyl 3-(8-((2-(3-methyl-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 96.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360348 (US9828369, Example 5 | methyl 3-(8-((1-(4-(trifluo...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360433 (US9828369, Example 6 | methyl 3-(8-((2-(4-phenoxyp...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 101 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360434 (US9828369, Example 7 | methyl 3-(8-((3-(tert-butyl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 111 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360444 (N-((5-(3-ethoxyphenyl)isoquinolin- 8-yl)methyl)-2-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 115 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360600 (1-([1,1'-biphenyl]-3-yl)-3-((5(3- methoxyphenyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 116 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360585 ((R/S)-2-(6-methoxynaphthalen-2-yl)- N-((5-(3-metho...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 118 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360435 (US9828369, Example 8 | methyl 3-(8-((1-phenyl-5- (...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 123 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360436 (US9828369, Example 9 | methyl 3-(8-((1-methyl-3-pr...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 132 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360437 (US9828369, Example 10 | methyl 3-(8-((spiro[2.4]he...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 162 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360438 (8-((isoquinoline-1- carboxamido)methyl)-5-(3- (met...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 164 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360545 (2-(4-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 178 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360439 (8-((isoquinoline-5- carboxamido)methyl)-5-(3- (me...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 196 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360586 (2-(6-methoxynaphthalen-2-yl)-N-((5- (3-methoxyphen...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 197 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360595 (1-(2,3-dichlorophenyl)-3-((5-(3,5- dimethoxyphenyl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 198 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360613 (US9828369, Example 172) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360582 (2-(2-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 213 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360542 (2-(3-bromophenyl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360543 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)sp...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 243 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360579 (2-(4-cyanophenyl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 256 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360573 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)bi...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC sid UniChem | US Patent | n/a | n/a | 268 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360447 (N-((5-(3- (methoxymethyl)phenyl)isoquinolin- 8-yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 278 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360489 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 291 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360581 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 298 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360537 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 305 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360498 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 306 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360484 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 317 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360588 ((R/S)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)- N-((5-(3-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 319 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360577 (2-([1,1'-biphenyl]-4-yl)-N-((5-(3- methoxyphenyl)i...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 324 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360569 ((R/S)-2-(3-fluoro-4- (trifluoromethyl)phenyl)-N-((...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 373 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360601 (1-(2,3-dichlorophenyl)-3-((5-(1- phenylyinyl)isoqu...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 374 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360574 (5-bromo-2-fluoro-N-((5-(3- methoxyphenyl)isoquinol...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360593 (N-((5-(3-methoxyphenyl)quinolin- 8-yl)methyl)-2-(4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 426 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360602 (1-(2,3-dichlorophenyl)-3-((5-(3- methoxypropyl)iso...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 478 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360509 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 479 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360524 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 483 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360547 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 483 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360580 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 484 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360566 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 513 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360451 ((1S,2S)-2-(4-methoxyphenyl)-N-((5- (3-methoxypheny...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 537 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360553 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 544 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360502 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360584 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 566 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360576 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 571 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360452 ((cis)-2-(4-methoxyphenyl)-N-((5-(3- methoxyphenyl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 589 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360551 ((trans)-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 589 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360540 (2-(4-chlorophenyl)-N-((5-(3 methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 597 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360505 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 602 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360525 (2'-hydroxy-N-((5-(3- methoxyphenyl)isoquinolin-8-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 602 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360507 (2-(2-(4-fluorophenyl)thiazol-4-yl)-N- ((5-(3-metho...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 609 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360583 ((R/S)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)- N-((5-(3-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 624 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360552 (2-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 696 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360472 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)qu...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 745 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360504 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 758 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360457 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 818 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360458 (2-(2,3-dichlorophenyl)-N-((5-(3- methoxyphenyl)iso...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 883 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360448 (N-((5-(3- isopropoxyphenyl)isoquinolin-8- yl)methy...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 888 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360534 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 889 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360533 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 902 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360544 (2-(2-bromophenyl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 915 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360589 ((R/S)-2-(4-isobutylphenyl)-N-((5-(3- methoxyphenyl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 923 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360594 (US9828369, Example 151) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 938 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360560 (1-benzyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 942 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360571 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 952 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360592 ((R/S)-2-(3,5- bis(trifluoromethyl)phenyl)-N-((5-(3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 974 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360527 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 988 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360490 (2-(2-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 993 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360596 (US9828369, Example 153 | methyl 2-(3-((5-(3- metho...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360555 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360546 (1-((4-chlorophenyl)sulfonyl)-N-((5-(3- methoxyphen...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360550 (2-(3-methoxyphenyl)-N-((5-(3- methoxyphenyl)isoqui...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360564 (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360590 (2-(3,5-bis(trifluoromethyl)phenyl)-N- ((5-(3-metho...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360530 (3'-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- y...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360603 (3-(8-((3-(2,3- dichlorophenyl)ureido)methyl)isoqui...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360520 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360441 (US9828369, Example 13 | methyl 3-(8-((1-methyl-1H-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360554 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360521 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360517 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360464 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)ox...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360538 (US9828369, Example 95 | tert-butyl 3-(2-(((5-(3- m...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360485 (2-(4-chlorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360529 (4'-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- y...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360570 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.42E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360471 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.43E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360526 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360531 (3'-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- y...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.56E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360470 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360499 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.64E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360511 (3-(3,5-dimethyl-1H-pyrazol-1-yl)-N- ((5-(3-methoxy...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360494 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.75E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360535 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360456 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.77E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360449 (US9828369, Example 20 | isopropyl 3-(8-((2- phenyl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360510 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360604 (US9828369, Example 162 | tert-butyl 4-(8-((3-(2,3-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360598 (US9828369, Example 155 | methyl 3-(8-((3-(2,3- dic...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.96E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360491 (2-(2-chlorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360508 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360578 (2-(3-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360459 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)q...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360453 (5-cyclopropyl-N-((5-(3- methoxyphenyl)isoquinolin-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360503 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360496 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360532 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360513 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360567 (2-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360605 (3-(4-(8-((3-(2,3- dichlorophenyl)ureido)methyl)iso...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360523 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360568 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.46E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360587 ((cis)-N-((5-(3-methoxyphenyl) isoquinolin-8-yl)met...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.56E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360497 (2-(3-chlorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360572 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360463 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360506 (2-(2,3-dihydrobenzo[b][1,4]dioxin-6- yl)-N-((5-(3-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360465 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)ox...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360597 (N-((5-(3-methoxyphenyl)isoquinolin-8- yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360558 (1-benzyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360561 (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360460 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360512 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360462 (3-ethyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360445 ((trans)-N-((5-(3- cyanophenyl)isoquinolin-8-yl)met...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360469 ((R/S)-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)me...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360528 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360495 (2-(3-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.71E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360446 (2-phenyl-N-((5-(3- (trifluoromethoxy)phenyl)isoqui...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360515 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360455 (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360575 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360514 (2-((5-hydroxy-1,2,3-oxadiazol-3(2H)- yl)methyl)-N-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360606 (1-(2,3-dichlorophenyl)-3-((5-(1- phenylethyl)isoqu...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360563 (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.24E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360607 (US9828369, Example 165 | tert-butyl 3-(8-((3-(2,3-...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360608 (1-(2,3-dichlorophenyl)-3-((5-(3- (morpholine-4- ca...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360609 (1-(2,3-dichlorophenyl)-3-((5-(2,5- dihydro-1H-pyrr...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.42E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360500 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360519 (4-(isoxazol-3-yl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.46E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360516 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.84E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360556 (1-benzyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360562 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360467 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)qu...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360557 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360450 (3-(8-((2- phenylcyclopropanecarboxamido) methyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360536 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360454 (3-(furan-2-yl)-N-((5-(3- methoxyphenyl)isoquinolin...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.83E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360591 (2-(3-chloro-4-cyclohexylphenyl)-N- ((5-(3-methoxyp...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360610 (1-([1,1'-biphenyl]-2-yl)-3-((5-(3- methoxyphenyl)i...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360565 (2-(5-bromopyridin-3-yl)-N-((5-(3- methoxyphenyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360501 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360461 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360541 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)sp...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360548 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360599 (US9828369, Example 156 | ethyl 3-(8-((3-(2,3-dichl...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360468 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.78E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360539 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360559 (2-(5-bromopyridin-2-yl)-2,2-difluoro- N-((5-(3-met...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360611 (1-(2,4-difluorophenyl)-3-((5-(3- methoxyphenyl)qui...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360522 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360612 (1-(2,3-dichlorophenyl)-3-((5-(3- methoxyphenyl)qui...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360518 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360466 (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360451 ((1S,2S)-2-(4-methoxyphenyl)-N-((5- (3-methoxypheny...) | Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.96E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
